Proteostasis Therapeutics, Inc. (NASDAQ: PTI) today announced positive study results across all three of the company’s CF pipeline programs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE